Background. Surgical site infections (SSIs) lead to increased patient morbidity and healthcare costs. Our objective was to decrease the SSI rate following gynecologic surgery. Methods. Adult patients undergoing abdominal surgery for gynecologic malignancy or benign disease received the following: patient education; preoperative antibacterial soap; appropriate antibiotic prophylaxis; change of gloves and use of clean instruments at surgical closure; surgical dressing for 48 h; and a post-discharge phone call. The baseline SSI rate was determined retrospectively (1 April 2014-30 June 2014), while the post-intervention SSI rate was determined prospectively (16 February 2015-15 October 2015. The main outcome was the overall SSI rate with secondary outcomes, including the rate of superficial, deep, incisional and organ space infection, as well as the cost effectiveness of the bundle. Results. A total of 232 baseline and 555 post-intervention patients were included in the study. No differences were observed between the baseline and post-intervention groups with regard to median body mass index (BMI), surgical approach, receipt of preoperative chemotherapy and/or radiation therapy, and cases including bowel surgery. Overall, the SSI rate decreased significantly from baseline Conclusions. This bundled intervention led to a significant decrease in the overall SSI rate and was cost effective. The largest decreases in SSIs were in incisional infections and following open surgery.
and/or radiation therapy, and cases including bowel surgery. Overall, the SSI rate decreased significantly from baseline [12. 5 %] to post-intervention [7. Conclusions. This bundled intervention led to a significant decrease in the overall SSI rate and was cost effective. The largest decreases in SSIs were in incisional infections and following open surgery.
Surgical site infections (SSIs) occur within the surgical skin incision or internally within the body following surgery. Development of SSIs adversely affects health outcomes and is associated with increased morbidity and mortality among cancer patients. [1] [2] [3] SSIs are also associated with increased medical costs, estimated to be up to $1.6 billion annually. [2] [3] [4] The rate of SSIs is reported by national agencies as a marker of the safety and quality of healthcare provided by an institution; the rate of SSIs following surgery for gynecologic malignancy has been estimated to be 10-15 %. 1 Given that the development of SSIs represents a substantial quality of care concern for the healthcare system, many quality-improvement initiatives have attempted to address this issue. [5] [6] [7] [8] [9] [10] [11] [12] There are varying levels of evidence to support individual interventions implemented during the preoperative, intraoperative and postoperative time periods. As a result, many institutions implement a 'bundle' of interventions aimed at decreasing the rate of SSIs rather than a single intervention. [13] [14] [15] To date, there is limited evidence regarding the effect of bundled initiatives on SSI rates following surgery for gynecologic malignancy. 15, 16 Furthermore, the cost-effectiveness analyses of such initiatives have not been reported. The objective of this report was to describe the results and cost effectiveness of a quality-improvement initiative to reduce the rate of SSIs within the Department of Gynecologic Oncology and Reproductive Medicine at a tertiary academic center specializing in cancer care.
METHODS

Study Design
Following Quality Improvement Assessment Board (QIAB) approval, which functions as the Institutional Review Board for quality-improvement research, we performed a retrospective review of all abdominal surgery cases completed within the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas MD Anderson Cancer Center from 1 April 2014-30 June 2014 to establish baseline SSI data. The length of time for the baseline and post-intervention periods were determined from a power analysis assuming a baseline rate of 15 %, with 80 % power to detect a 50 % reduction in the SSI rate using a one-sided a = 0.05. SSI was defined as an infection of the surgical incision or organ space requiring antibiotics within 30 days of surgery. This definition was chosen instead of the more restrictive definitions used by reporting agencies as we wished to include all SSI cases. 17 , 18 Receipt of antibiotics to treat an infection is an objective measure with clinical impact on the patient. Data for the post-intervention period (16 February 2015-15 October 2015) were captured prospectively following implementation of the intervention bundle for all abdominal surgery cases performed within our department.
The types of SSIs described in this manuscript were adapted from the definitions endorsed by the Centers for Disease Control and Prevention: superficial SSI involves the skin to the level above the fascia; deep SSI involves the fascia and/or muscle layer; and organ space infections (OSIs) involve any part of the body deeper than the fascial/muscle layers that is opened or manipulated during the operative procedure. 19 Given the similarities in the pathophysiology of preventing and developing superficial and deep SSIs, as well as the possible ambiguity of differentiating these types of SSIs based on available documentation, these two SSI categories were also combined and defined as incisional SSIs. Superficial or deep SSIs could be present with OSIs. Cases performed jointly with other surgical services were excluded.
The direct costs of the intervention were determined from the hospital dispensary. The cost of SSIs was determined, from the hospital perspective, using data from the Department of Clinical Revenue and Reimbursement. As Medicare does not reimburse for readmissions due to SSIs within 30 days of surgery, the cost of readmission due to SSIs is a financial loss to the hospital. The paid amounts received from private insurance carriers who provided reimbursement for hospital readmissions related to treatment of SSIs within the 30-day postoperative period were used to create an average value for the cost of each type of SSI. When comparing costs between the baseline and postintervention periods, the 3-month baseline period was extrapolated to be equal to the 8-month post-intervention period. The cost to the hospital during the post-intervention period included the cost of the intervention bundle, as well as the estimated cost related to SSI readmission. The unit of effectiveness was defined as the change in the overall SSI rate between the baseline and post-intervention periods.
Intervention Bundle
A bundled intervention was implemented for all abdominal surgeries beginning 16 February 2015. The intervention bundle included evidence-based measures adapted to our institutional practices. The preoperative interventions included showering with antibacterial soap the night before and morning of surgery, and receiving appropriate prophylactic antibiotics with appropriate timing and dose before surgical incision. [12] [13] [14] 20, 21 Preoperative antibiotics were standardized based on the 2013 joint antimicrobial prophylaxis guidelines by the American Society of Health-System Pharmacists (ASHP), the Infectious Diseases Society of America (IDSA), the Surgical Infection Society (SIS), and the Society for Healthcare Epidemiology of America (SHEA). 22 Antibiotic options included cefazolin or cefoxitin (preferred option for bowel surgery) or combination clindamycin and ciprofloxacin for penicillin-allergic patients. 22 Intraoperative interventions included appropriately redosing antibiotics, using separate sterile instruments, suction tip, electrocautery device, and gloves for fascial and skin closure and changing gowns if vaginal or perineal contamination. 13, 14, 20 Finally, the postoperative interventions included labeling the surgical dressing in the operating room with the date and time for removal on the second postoperative day (24-48 h postoperatively), providing patient education handouts regarding signs and symptoms of SSIs, and giving a follow-up phone call to the patient 48-72 h after surgery with further SSI education and assessment.
11,13,14
Statistical Analysis
Patient demographics, clinical characteristics and SSI rates were compared between the baseline and post-intervention groups using the Fisher's exact test and MannWhitney test. Categorical and continuous variables were described using proportions and measures of central tendency, respectively. Multivariate exact logistic regression analyses of the SSI outcomes were performed, with the inclusion of all covariates significant to less than p = 0.25 on univariate analysis. Backward elimination was then performed until only covariates significant to p \ 0.05 remained. The main outcome was the overall rate of SSIs, with stratification by implementation period of the intervention bundle. Secondary outcomes included the rate of superficial, deep, incisional, and OSIs, as well as the cost effectiveness of the bundled intervention. OSIs could be present concurrently with either superficial or deep infections. Variables assessed for inclusion in the multivariate analysis included use of the intervention bundle, surgical approach, current smoking status, receipt of appropriate prophylactic antibiotics, appropriate redosing of antibiotics, body mass index [BMI] (stratified as \25, 25-30, [30 kg/m 2 ), race (White vs. non-White), age, estimated blood loss (EBL), having a Charlson Comorbidity Index score [1, diabetes, receipt of preoperative chemotherapy, receipt of preoperative radiation, surgical time, and undergoing bowel surgery. All covariates were binary (yes/ no) except for age, EBL, BMI, and surgical time. Model diagnostics were assessed and no major assumptions were violated. A p value B0.05 indicated statistical significance for all comparisons and analyses of primary and secondary outcomes. Statistical assessment was two-sided when comparing demographic characteristics, and one-sided for SSI outcomes. Stata Ò version 13.1 statistical software was used for all statistical analyses (StataCorp LP, College Station, TX, USA).
RESULTS
Overall, 232 baseline surgical cases were compared with 555 post-intervention surgical cases. Patient demographics for the baseline and post-intervention groups are shown in Table 1 . No significant differences were observed between the groups with regard to median BMI (28.9 vs. 29.4 kg/ m 2 ; p = 0.30), surgical approach (laparotomy 48 vs. 41 %; p = 0.06), receipt of preoperative chemotherapy (17 vs. 14 %; p = 0.18) or radiation therapy (2 vs. 1 %; p = 0.54), and bowel surgery (23 vs. 21 %; p = 0.39). Compliance with the bundled intervention was tracked by survey and chart review by members of the quality-improvement team. Compliance with the intervention bundle, except for receipt of appropriate preoperative antibiotics, ranged from 84 to 94 % throughout the study period. The initial compliance with appropriate receipt of preoperative antibiotic was 62 %; however, this increased to 74 % by the end of the study period.
As shown in Fig. 1 , implementation of the intervention bundle correlated with a decrease in the overall SSI rate from baseline [12. On multivariate analysis, the intervention bundle remained significantly correlated with a decreased overall likelihood of developing SSIs (OR 0.64, 90 % CI 0.41-0.98; p = 0.04) [ Table 3 ]. Appropriate redosing of intraoperative antibiotics was also found to be protective against developing an SSI on multivariate analysis (OR 0.45, 90 % CI 0.24-0.87; p = 0.02). Factors associated with an increase in the rate of SSIs on multivariate analysis included laparotomy (OR 4.90, 90 % CI 3.01-7.98; p \ 0.001) and current smoker (OR 1.95, 90 % CI 1.03-3.69; p = 0.04).
The cost of the bundled intervention was estimated to be $1336.25 per month, or $19.26 per case (Table 4) . This included the one-time cost of purchasing additional surgical trays for the closure of the skin and fascia. Personnel costs were not included in the analysis as all team members assisted with the initiative as part of their regular employment. However, a sensitivity analysis was performed that included theoretical personnel costs.
The cost of each type of SSI, from the hospital perspective, is shown in Table 2 . For the cost-effectiveness analysis, the types of SSIs were considered to be mutually exclusive. If a patient developed a superficial, deep and organ space infection, it was calculated as only an OSI so as to not overestimate the amount saved. In addition, the overall amount saved only included the values for the superficial, deep and organ space infections as the values for the incisional SSIs are included within the superficial and deep SSI values. The estimated amount saved through avoidance of SSIs during the study period was $535,686, or $66,961 per month. After factoring in the cost of the intervention bundle, the amount saved was $524,996, or $65,625 per month. The intervention group was found to be more effective (lower rate of SSIs) and less expensive than the non-intervention group.
Three sensitivity analyses were performed in order to test the robustness of the cost-effectiveness analyses. First, the efficacy of the bundled intervention was reduced by 50 %. In this scenario, the amount saved through avoidance of SSIs was $262,877, or $32,859 per month, and the intervention was still cost-saving and resulted in net savings of $252,187, or $31,523 per month. Second, the cost to the hospital of SSIs was reduced by 75 %. Even with a 75 % decrease in the cost of readmission to treat SSIs, the intervention remained cost-saving, with a net savings of $123,232, or $15,404 per month. Lastly, the cost of the intervention bundle was increased by adding personnel costs equivalent to the standard yearly salary of a research data coordinator at this institution of $37,000. 23 In this scenario, the cost of the intervention bundle was estimated to be $47,619, or averaged to be $85.80 per case. The intervention remained net cost-saving with an overall reduction in cost of $488,067, or $61,008 per month. Finally, a worst-case scenario was performed in which the SSI surgical site infection, OR odds ratio, CI confidence interval, OSI organ space infection a As incisional SSIs represent a combination of superficial and deep SSIs, rates and costs associated with incisional SSIs were not included in the overall calculations; only data related to superficial, deep and OSI SSIs were included in the overall calculations b Superficial or deep SSIs could be present with OSIs and were not considered mutually exclusive when calculating the overall SSI rate OR odds ratio, CI confidence interval, BMI body mass index, EBL estimated blood loss efficacy was reduced by 50 %, the cost of SSI readmission was reduced by 75 %, and the cost of the intervention was increased by additional personnel costs. In this scenario, the intervention still resulted in a net savings of $19,342, or $2418 per month. In all of these scenarios, the intervention group remained dominant and was cost effective compared with the non-intervention group.
DISCUSSION
SSIs are potentially avoidable postoperative complications. Implementation of the described bundled intervention significantly decreased the overall rate of SSIs from 12.5 to 7.4 %. The largest improvements were seen in the rate of incisional SSIs and the rate of SSIs following laparotomy. Our results are consistent with results reported by other initiatives. Duke University and the Mayo Clinic have implemented bundled interventions following colorectal and gynecologic surgery, with decreases in SSI rates from 50 to 80 %. 13, 14, 16 Among high-risk gynecologic oncology patients, Novetsky et al. implemented a five-part bundled intervention, with reduction in the rate of SSIs by 60 %. 15 The intervention was also cost effective; we estimate that it could reduce hospital costs by over $65,000 per month. While previous studies have addressed reducing the morbidity associated with SSIs, the literature evaluating the cost effectiveness of SSI reduction interventions is limited. Previous studies have described the cost effectiveness of single interventions but not the effect of implementing a bundled intervention. 24, 25 Other studies have described the estimated costs associated with certain types of infections, but not a full cost assessment of implementing a bundled intervention. 13 While it is important to decrease patient morbidity through a reduction in the SSI rate, it is also pertinent to assess and analyze the cost effectiveness of these quality-improvement initiatives. Future informed decisions to optimize the delivery of high-quality healthcare will depend on the efficacy of different interventions and their cost effectiveness. A limitation of this analysis was that detection of SSIs was dependent on adequate documentation in the clinical record, and could be subjective. Furthermore, as there was concurrent education of the clinical care teams regarding SSIs related to this initiative, it was possible that the superficial SSI rate declined, in part, due to more restrictive antibiotic dispensing and clearer documentation. However, all subtypes of SSIs decreased in rate between the baseline and post-intervention periods, even the less subjective subtypes of deep infection and OSI, a benefit that was not likely due to reporting bias. This analysis could only assess the effect of the bundled intervention as a whole and the contributions of the individual components of the intervention could not be evaluated. Finally, this initiative was implemented at a large academic cancer center and the results, especially the cost analysis, may not be applicable to all settings as insurance reimbursements vary significantly between healthcare locations.
The strengths of this initiative include the prospective review of all surgical cases in order to provide frequent, relevant feedback to the clinical care teams. Other published quality-improvement initiatives have relied on national agencies, which can lag months behind in reporting results and have varying inclusion criteria for review of surgical cases. 13, 14, 17, 18 In addition, by including all abdominal surgery cases, our results are applicable to all patients undergoing surgery for gynecologic malignancy or benign gynecologic disease. This is in contrast to other studies that evaluated only certain high-risk groups. 15, 26, 27 CONCLUSIONS This quality-improvement initiative utilizing a bundled intervention reduced the overall rate of SSIs following surgery for gynecologic malignancy. The initiative was cost effective and led to substantial reductions in hospital costs. Reduction of SSIs is a high-impact goal leading to improvement in the quality of patient care and reduction in healthcare costs. Additional study is needed to define the optimal components of the intervention bundle and to confirm sustainability. 
